Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report
Authors:
- Natalia V. ZamoraNZNatalia V. Zamora
- Robin ChristensenRCRobin Christensen
- Niti GoelNGNiti Goel
- Louise KlokkerLKLouise Klokker
- Maria A. Lopez-OlivoMLMaria A. Lopez-Olivo
- Lars E. KristensenLKLars E. Kristensen
- Loreto CarmonaLCLoreto Carmona
- Vibeke StrandVSVibeke Strand
- Jeffrey R. CurtisJCJeffrey R. Curtis
- Maria E. Suarez-AlmazorMSMaria E. Suarez-Almazor
- 15 June 2017
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 44 (12) , 1894-1898
Abstract
Objective.: Outcomes important to patients are those that are relevant to their well-being, including quality of life, morbid endpoints, and death. These outcomes often occur over the longterm and can be identified in prospective longitudinal observational studies (PLOS). There are no standards for which outcome domains should be considered. Our overarching goal is to identify critical longterm outcome domains for patients with rheumatic diseases, and to develop a conceptual framework to measure and classify them within the scope of OMERACT Filter 2.0.Methods.: The steps of this initiative primarily concern rheumatoid arthritis (RA) and include (1) performing a systematic review of RA patient registries and cohorts to identify previously collected and reported outcome domains and measurement instruments; (2) developing a conceptual framework and taxonomy for identification and classification of outcome domains; (3) conducting focus groups to identify domains considered critical by patients with RA; and (4) surveying patients, providers, and researchers to identify critical outcomes that can be evaluated through the OMERACT filter.Results.: In our initial evaluation of databases and registries across countries, we found both commonalities and differences, with no clear standardization. At the initial group meeting, participants agreed that additional work is needed to identify which critical outcomes should be collected in PLOS, and suggested several: death, independence, and participation, among others. An operational strategy for the next 2 years was proposed.Conclusion.: Participants endorsed the need for an initiative to identify and evaluate critical outcome domains and measurement instruments for data collection in PLOS.Keywords
This publication has 14 references indexed in Scilit:
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.American Journal of Epidemiology, 2016
- Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational RegistriesArthritis Care & Research, 2015
- Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0Journal of Clinical Epidemiology, 2014
- Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registriesAnnals of the Rheumatic Diseases, 2014
- Non‐randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventionsResearch Synthesis Methods, 2013
- Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO studyRheumatology, 2012
- Issues relating to study design and risk of bias when including non‐randomized studies in systematic reviews on the effects of interventionsResearch Synthesis Methods, 2012
- Examining the Similarities and Differences of OMERACT Core Sets Using the ICF: First Step Towards an Improved Domain Specification and Development of an Item Pool to Measure Functioning and HealthThe Journal of Rheumatology, 2011
- EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatologyAnnals of the Rheumatic Diseases, 2010
- Registries for Robust EvidenceJAMA, 2009